144 related articles for article (PubMed ID: 23731704)
21. The association of CGG repeats in the FMR1 gene and timing of natural menopause.
Voorhuis M; Onland-Moret NC; Fauser BC; Ploos van Amstel HK; van der Schouw YT; Broekmans FJ
Hum Reprod; 2013 Feb; 28(2):496-501. PubMed ID: 23154068
[TBL] [Abstract][Full Text] [Related]
22. Can egg donor selection be improved?--A pilot study.
Gleicher N; Weghofer A; Barad DH
Reprod Biol Endocrinol; 2010 Jun; 8():76. PubMed ID: 20576154
[TBL] [Abstract][Full Text] [Related]
23. Can the FMR1 (fragile X) gene serve as predictor of response to ovarian stimulation?
Gleicher N; Weghofer A; Oktay K; Barad DH
Reprod Sci; 2009 May; 16(5):462-7. PubMed ID: 19116286
[TBL] [Abstract][Full Text] [Related]
24. Prevalence and instability of fragile X alleles: implications for offering fragile X prenatal diagnosis.
Cronister A; Teicher J; Rohlfs EM; Donnenfeld A; Hallam S
Obstet Gynecol; 2008 Mar; 111(3):596-601. PubMed ID: 18310361
[TBL] [Abstract][Full Text] [Related]
25. Intra-individual stability over time of standardized anti-Mullerian hormone in FMR1 premutation carriers.
Spath MA; Feuth TB; Allen EG; Smits AP; Yntema HG; van Kessel AG; Braat DD; Sherman SL; Thomas CM
Hum Reprod; 2011 Aug; 26(8):2185-91. PubMed ID: 21576079
[TBL] [Abstract][Full Text] [Related]
26. Can FMR1 CGG repeat lengths predict the outcome in ICSI cycles?
Cogendez E; Ozkaya E; Eser AÇ; Eken M; Karaman A
Ginekol Pol; 2022; 93(9):735-741. PubMed ID: 35072235
[TBL] [Abstract][Full Text] [Related]
27. Hypoandrogenism in association with diminished functional ovarian reserve.
Gleicher N; Kim A; Weghofer A; Kushnir VA; Shohat-Tal A; Lazzaroni E; Lee HJ; Barad DH
Hum Reprod; 2013 Apr; 28(4):1084-91. PubMed ID: 23427231
[TBL] [Abstract][Full Text] [Related]
28. Analysis of the molecular parameters that could predict the risk of manifesting premature ovarian failure in female premutation carriers of fragile X syndrome.
Tejada MI; García-Alegría E; Bilbao A; Martínez-Bouzas C; Beristain E; Poch M; Ramos-Arroyo MA; López B; Fernandez Carvajal I; Ribate MP; Ramos F
Menopause; 2008; 15(5):945-9. PubMed ID: 18427356
[TBL] [Abstract][Full Text] [Related]
29. The 'normal' range of FMR1 triple CGG repeats may be associated with primary ovarian insufficiency in China.
Lu CL; Li R; Chen XN; Xu YY; Yan LY; Yan J; Zhang YY; Jin HY; Zhang WX; Qiao J; Zhen XM
Reprod Biomed Online; 2017 Feb; 34(2):175-180. PubMed ID: 27916452
[TBL] [Abstract][Full Text] [Related]
30. Does the presence of AGG interruptions within the CGG repeat tract have a protective effect on the fertility phenotype of female FMR1 premutation carriers?
Friedman-Gohas M; Kirshenbaum M; Michaeli A; Domniz N; Elizur S; Raanani H; Orvieto R; Cohen Y
J Assist Reprod Genet; 2020 Apr; 37(4):849-854. PubMed ID: 32096109
[TBL] [Abstract][Full Text] [Related]
31. Increased frequency of occult fragile X-associated primary ovarian insufficiency in infertile women with evidence of impaired ovarian function.
Karimov CB; Moragianni VA; Cronister A; Srouji S; Petrozza J; Racowsky C; Ginsburg E; Thornton KL; Welt CK
Hum Reprod; 2011 Aug; 26(8):2077-83. PubMed ID: 21646280
[TBL] [Abstract][Full Text] [Related]
32. Elevated prevalence of 35-44 FMR1 trinucleotide repeats in women with diminished ovarian reserve.
Pastore LM; Young SL; Baker VL; Karns LB; Williams CD; Silverman LM
Reprod Sci; 2012 Nov; 19(11):1226-31. PubMed ID: 22581803
[TBL] [Abstract][Full Text] [Related]
33. Does theFMR1 gene affect IVF success?
Pastore LM; Christianson MS; McGuinness B; Vaught KC; Maher JY; Kearns WG
Reprod Biomed Online; 2019 Apr; 38(4):560-569. PubMed ID: 30711457
[TBL] [Abstract][Full Text] [Related]
34. High normal sized CGG repeat on the FMR1 gene reduces live birth rates after in vitro fertilization in Han Chinese.
Zhou X; Shi W; Ye M; Chen S; Xu N; Xu C
Gene; 2022 Apr; 819():146204. PubMed ID: 35101584
[TBL] [Abstract][Full Text] [Related]
35. CGG repeat length and AGG interruptions as indicators of fragile X-associated diminished ovarian reserve.
Lekovich J; Man L; Xu K; Canon C; Lilienthal D; Stewart JD; Pereira N; Rosenwaks Z; Gerhardt J
Genet Med; 2018 Sep; 20(9):957-964. PubMed ID: 29267266
[TBL] [Abstract][Full Text] [Related]
36. [Serum levels of anti-muller hormone in women with polycystic ovary syndrome and healthy women of reproductive age].
Parahuleva N; Pehlivanov B; Orbecova M; Deneva T; Uchikova E
Akush Ginekol (Sofiia); 2013; 52 Suppl 1():16-23. PubMed ID: 24294740
[TBL] [Abstract][Full Text] [Related]
37. Toward a better understanding of functional ovarian reserve: AMH (AMHo) and FSH (FSHo) hormone ratios per retrieved oocyte.
Gleicher N; Kim A; Weghofer A; Barad DH
J Clin Endocrinol Metab; 2012 Mar; 97(3):995-1004. PubMed ID: 22170712
[TBL] [Abstract][Full Text] [Related]
38. Use of ovarian reserve parameters for predicting live births in women undergoing in vitro fertilization.
Lukaszuk K; Kunicki M; Liss J; Lukaszuk M; Jakiel G
Eur J Obstet Gynecol Reprod Biol; 2013 Jun; 168(2):173-7. PubMed ID: 23485092
[TBL] [Abstract][Full Text] [Related]
39. Analysis of FMR1 gene expression in female premutation carriers using robust segmented linear regression models.
García-Alegría E; Ibáñez B; Mínguez M; Poch M; Valiente A; Sanz-Parra A; Martinez-Bouzas C; Beristain E; Tejada MI
RNA; 2007 May; 13(5):756-62. PubMed ID: 17449730
[TBL] [Abstract][Full Text] [Related]
40. Age at menarche: a predictor of diminished ovarian function?
Weghofer A; Kim A; Barad DH; Gleicher N
Fertil Steril; 2013 Oct; 100(4):1039-43. PubMed ID: 23809497
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
